MDSpire - Summary
FDA & Government News

FDA Clears AI Guidance Tool for Mitral Repair

AI enhances real-time intraprocedural visualization and navigation.

Share

The FDA has granted 510(k) clearance for EchoNavigator R5.0 with DeviceGuide, a sophisticated AI software by Royal Philips designed to aid minimally invasive mitral valve repair procedures. This software enhances visualization and tracking of devices during treatments for mitral regurgitation, impacting millions globally. It seamlessly integrates with the Philips Azurion platform, utilizing echo-fluoro fusion technology. Developed alongside Edwards Lifesciences, DeviceGuide aims to optimize procedural workflows and improve precision, while allowing physicians to maintain full control.

Original Source(s)

FDA Clears AI Guidance Tool for Mitral Repair

  • by Kathryn Wighton

  • March 26, 2026

Related Content

Gonococcal Endocarditis Diagnosed by PCR

Case highlights diagnostic challenges when blood cultures are negative and embolic complications are present

A Closer Look at Vascular Cell States in Marfan Syndrome

Single-cell proteomics identifies Marfan-enriched smooth muscle states and endothelial transition signatures

  • March 25, 2026

  • 2 min
Japan Clears First iPSC Therapies for Clinical Use 

Two iPSC-derived cell therapies receive time-limited authorization following early clinical trials

  • March 25, 2026

  • 2 min